Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Type and population of the study

PS Pegdwendé Abel Sorgho
JM Jeremy James Martinson
FD Florencia Wendkuuni Djigma
AY Albert Théophane Yonli
BN Bolni Marius Nagalo
TC Tegwinde Rebeca Compaore
DO Dorcas Obiri-Yeboah
BD Birama Diarra
HS Herman Karim Sombie
AZ Arsène Wendpagnangdé Zongo
AO Abdoul Karim Ouattara
SS Serge Théophile R. Soubeiga
LT Lassina Traore
LR Lewis R. Roberts
JS Jacques Simpore
ask Ask a question
Favorite

This was a prospective study conducted from January to September 2017. A total of 244 individuals aged 18 and over and divided into two groups were included in this study. The first group consisted of 110 carriers for chronic HBV (HBsAg positive > six months) recruited at the Pietro Annigoni Biomolecular Research Center (CERBA/LABIOGENE). The second group included 134 negative controls subjects for HBV, HCV, and HIV recruited at the Regional Blood Transfusion Center of Ouagadougou (CRTS/O).

Copyright and License information:  ©2018
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. www.mjhid.org Mediterr J Hematol Infect Dis 2018; 10; e2018060

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A